Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Not applicable Interventional

Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis

ClinicalTrials.gov ID: NCT04677465

Public ClinicalTrials.gov record NCT04677465. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 10:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients With COPD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective, randomized, parallel group, double-blind, sham-controlled, multicenter clinical trial following patients to 2 years. The objective is to assess the safety and effectiveness of Bronchial Rheoplasty for the treatment of the symptoms of chronic bronchitis in adult COPD patients with moderate to severe chronic bronchitis. A total of 270 patients will be randomized at up to 40 study centers in the United States, Canada, and Europe.

Study identification

NCT ID
NCT04677465
Recruitment status
Not listed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Gala Therapeutics, Inc.
Industry
Enrollment
270 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
35 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 6, 2021
Primary completion
Apr 30, 2024
Completion
Sep 30, 2025
Last update posted
Jun 26, 2023

2021 – 2025

United States locations

U.S. sites
31
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
Norton Thoracic Phoenix Arizona 85013
Honor Health Scottsdale Arizona 85258
Syed M. Alam, MD Pulmonology (Bakersfield Heart) Bakersfield California 93309
UC Davis Medical Center Davis California 95817
Scripps Health Encinitas California 92024
University of Southern California Los Angeles California 90033
UCLA Harbor Lundquist Institute Torrance California 90502
University of Colorado Aurora Colorado 80045
Mayo Clinic Jacksonville Florida 32224
The Cardiac and Vascular Institute Research Foundation Tallahassee Florida 32605
Emory University Atlanta Georgia 30322
OSF Saint Francis Medical Center Peoria Illinois 61637
University of Kansas School of Medicine Kansas City Kansas 66160
Tulane University Medical Center New Orleans Louisiana 70112
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Lahey Hospital and Medical Center Burlington Massachusetts 01805
University of Michigan Ann Arbor Michigan 48109
Minnesota Lung Center Minneapolis Minnesota 55407
Mayo Clinic Rochester Minnesota 55905
University of Mississippi Jackson Mississippi 39216
Pinehurst Medical Clinic Pinehurst North Carolina 28374
University of Pennsylvania Philadelphia Pennsylvania 19104
Temple University Philadelphia Pennsylvania 19140
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
CHI Memorial Research Center Chattanooga Tennessee 37404
Vanderbilt University Medical Center Nashville Tennessee 37212
JPS Health Network, Fort Worth Fort Worth Texas 76104
Houston Methodist Houston Texas 77030
Virginia Commonwealth University Health Richmond Virginia 23298
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04677465, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2023 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04677465 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →